Regulatory Concerns Over Psychoactive Component in Kratom

This chapter examines the psychoactive compound 7-OH in kratom and the FDA's concerns over its synthetic enhancement in products. It discusses potential risks, including dependence and the ongoing efforts by health agencies to regulate this substance.